B-type natriuretic peptide as a predictor of declining cognitive function and dementia—a cohort study of an elderly general population with a 5-year follow-up

References

• Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60: 1119–22.
   PubMed Web of Science ®Google Scholar
• Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166: 367–78.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, . Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336–42.
   PubMed Web of Science ®Google Scholar
• Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, . Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology. 1993;43:13–20.
   Google Scholar
• Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, . Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998;351:1840–3.
   PubMed Web of Science ®Google Scholar
• Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585:97–108.
   PubMed Web of Science ®Google Scholar
• Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, Jefferson AL, . Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease. Am J Cardiol. 2006;98:538–40.
   PubMed Web of Science ®Google Scholar
• Feola M, Rosso GL, Peano M, Agostini M, Aspromonte N, Carena G, . Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure. Arch Med Res. 2007;38:234–9.
   PubMed Web of Science ®Google Scholar
• Buerger K, Ernst A, Ewers M, Uspenskaya O, Omerovic M, Morgenthaler NG, . Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. Biol Psychiatry. 2009;65:979–84.
   PubMed Web of Science ®Google Scholar
• Zung WW. A self-rating Depression Scale. Arch Gen Psychiatry. 1965;12:63–70.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994. 143–7.
   Google Scholar
• McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, . Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop. Neurology. 1996;47:1113–24.
   PubMed Web of Science ®Google Scholar
• Ala-Kopsala M, Magga J, Peuhkurinen K, Leipala J, Ruskoaho H, Leppaluoto J, . Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem. 2004;50:1576–88.
   PubMed Web of Science ®Google Scholar
• Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, . Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551–6.
   PubMed Web of Science ®Google Scholar
• Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609–16.
   PubMed Web of Science ®Google Scholar
• Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C, Baldereschi M, . Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000; 54:16–20.
   Web of Science ®Google Scholar
• Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, . Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology. 1998;17:14–20.
   PubMed Web of Science ®Google Scholar
• Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, . Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21: 49–55.
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, . Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62:1556–60.
   PubMed Web of Science ®Google Scholar
• Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, . Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45:1161–8.
   PubMed Web of Science ®Google Scholar
• Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002;58:1175–81.
   PubMed Web of Science ®Google Scholar
• Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996;312:805–8.
   PubMed Web of Science ®Google Scholar
• Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, . Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–51.
   PubMed Web of Science ®Google Scholar
• Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001;22:407–12.
   PubMed Web of Science ®Google Scholar
• Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GY. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation. 2004; 110:1794–8.
   PubMed Web of Science ®Google Scholar
• Ewers M, Mielke MM, Hampel H. Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol. 2010;45:75–9.
   Google Scholar
• Zuliani G, Cavalieri M, Galvani M, Passaro A, Munari MR, Bosi C, . Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J Neurol Sci. 2008;272:164–70.
   Google Scholar
• Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, . Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol. 2004;61:668–72.
   PubMed Web of Science ®Google Scholar
• Dziedzic T. Systemic inflammatory markers and risk of dementia. Am J Alzheimers Dis Other Demen. 2006;21: 258–62.
   PubMedGoogle Scholar
• Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, . Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the cardiovascular health study. Arch Intern Med. 2009;169: 1195–202.
   PubMed Web of Science ®Google Scholar
• Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem. 2005;40:1–36.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Hosoda K, . Rat brain natriuretic peptide—tissue distribution and molecular form. Endocrinology. 1990;126:2225–7.
   PubMed Web of Science ®Google Scholar